Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer

Oncology Reports

Volumn 19, Issue 1, 2008, Pages 197-202

  Kitajima, Yoshihiko ^a   Ohtaka, Kazuma ^a   Mitsuno, Mayumi ^a   Tanaka, Masayuki ^a   Sato, Seiji ^a   Nakafusa, Yuji ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Helicobacter pylori; Methylation; Runx3

Indexed keywords

DNA; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; EARLY CANCER; FEMALE; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

EID: 38749127594     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.1.197     Document Type: Article

References (22)

1. Ito Y and Miyazono K: Runx transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13: 43-47, 2003.
2. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y: Causal relationship between the loss of runx3 expression and gastric cancer. Cell 109: 113-124, 2002.
3. Smith MG, Hold GL, Tahara E and El-Omar EM: Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12: 2979-2990, 2006.
4. Fukamachi H, Ito K and Ito Y: Runx-/- gastric epithelial cells differentiate into intestinal type cells. BBRC 321: 58-64, 2004.
5. Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K and Yasui W: Frequent loss of runx3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 71: 137-143, 2004.
6. Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ and Kang GH: Methylation of runx3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84: 479-484, 2004.
7. Eslick GD, Lim LL, Byles JE, Xia HH and Talley NJ: Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94: 2373-2379, 1999.
8. Tsuji S, Tsuji M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S and Hayashi N: Helicobacter pylori eradication to prevent gastric cancer: Underlying molecular and cellular mechanisms. World J Gastroenterol 12: 1671-1680, 2006.
9. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 829-832, 2001.
10. Blaser MJ, Peres-Peres GI, Kleanthous H, Cover TL, Peak RM, Chyou PH, Stemmermann GN and Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. CancerRes 55: 2111-2115, 1995.
11. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M and Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995, 2006.
12. Yamazaki S, Kato S, Matsukura N, Ohtani M, Ito Y, Suto H, Yamazaki Y, Yamakawa A, Tokudome S, Higashi H, Hatakeyama M and Azuma T: Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. FEMS 44: 261-268, 2005.
13. Japanese research Society for Gastric Cancer Japanese Classification of Gastric Carcinoma (1st English edition) Kanehara, Tokyo, 1995.
14. Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S and Miyazaki K: The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. J Gastroenterol 41: 133-139, 2006.
15. Kang GH, Lee S, Lee HJ and Hwang KS: Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prognostic imtraepithelial neoplasia. J Pathol 202: 233-240, 2004.
16. So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S and Motoyama T: Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 97: 1155-1158, 2006.
17. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH and Kim JS: Aberrant Cpg island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163: 1551-1556, 2003.
18. Hamilton S and Aaltonen L (ed). Pathology and Genetics. In: Tumours of the Digestive System. WHO Classification of Tumours, ARC Press, 2000.
19. Zsikla V, Hailemariam S, Baumann M, Mund MT, Schaub N, Meier R and Cathomas G: Increased rate of Helicobacter pylori infection detected by PCR in biopsies with chronic gastritis. Am J Surg Pathol 30: 242-248, 2006.
20. Chan A O-O, Lam SK, Wong CY, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A and Kwong YL: Promoter methylation of E-cadherin geen in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52: 502-505, 2003.
21. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S and Hatakeyama M: Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447: 330-333, 2007.
22. Blaser MJ and Atherton JC: Helicobacter pylori persistence: biology and disease. J Clin Invest 113: 321-333, 2004.